银屑病关节炎患者的骨簇吸收
在1303例银屑病关节炎患者的前瞻性观察队列中,526例(40.4%)存在骨簇吸收,其中181例(34.4%)在随访期间新发。骨簇吸收与年龄较大、病程较长、影像学关节破坏计数较高、中轴疾病及使用过的改善病情抗风湿药数量相关;男性、椎体骨量减少和使用非甾体抗炎药与骨簇吸收发生相关,使用生物制剂和靶向合成改善病情抗风湿药具有保护作用(HR 0.70,p=0.05),但在5%水平未达显著。
要点
- 银屑病关节炎患者中骨簇吸收患病率为40.4%(526/1303)。
- 骨簇吸收与更严重的疾病相关,包括外周和中轴影像学损伤。
- 使用生物制剂和靶向合成改善病情抗风湿药与骨簇吸收发生风险降低相关(HR 0.70,p=0.05),但在5%水平未达显著。
核心结论
- 骨簇吸收是银屑病关节炎常见的影像学特征,与更严重的疾病相关,包括外周和中轴影像学损伤。
研究设计与样本
- 研究纳入前瞻性观察队列中随访的银屑病关节炎患者,共1303例。
- 骨簇吸收定义为手指或足趾末端骨簇的吸收性改变。
- 采用广义估计方程分析横断面与骨簇吸收相关的临床和影像学特征,采用多因素Cox回归分析确定与骨簇吸收发生相关的因素。
主要发现
- 1303例患者中526例(40.4%)观察到骨簇吸收,其中181例(34.4%)在随访期间发生骨簇吸收。
- 骨簇吸收与年龄较大(OR 1.49,p<0.01)、银屑病关节炎病程较长(OR 1.03,p<0.01)、影像学破坏关节计数较高(OR 1.02,p=0.04)、中轴疾病(OR 1.73,p<0.01)及使用过的全身改善病情抗风湿药数量(OR 1.27,p<0.01)相关。
- 男性(HR 1.54,p=0.01)、椎体骨量减少(HR 1.39,p=0.02)和使用非甾体抗炎药(HR 1.43,p=0.03)与骨簇吸收的发生相关。
- 使用生物制剂和靶向合成改善病情抗风湿药具有保护作用(HR 0.70,p=0.05),但在5%水平未达显著。
局限性
- 使用生物制剂和靶向合成改善病情抗风湿药的保护作用(HR 0.70,p=0.05)在5%水平未达显著。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Tuft resorption (TR) is an important radiographic feature of psoriatic arthritis (PsA). We aimed to define the prevalence of TR in patients with PsA, the clinical and radiographic features associated with it, and the risk factors for its occurrence. METHODS: We included patients with PsA followed at our prospective observational cohort. We defined TR as resorptive changes in the terminal tufts of the fingers or toes. We used generalized estimating equations to characterize clinical and radiographic features cross-sectionally associated with TR. We used multivariate Cox regression analysis to identify factors associated with the development of TR. RESULTS: Of the 1303 patients included in the study, 526 (40.4 %) were observed to have TR, of whom 181 (34.4 %) developed it during follow-up. TR was associated with older age (OR 1.49, p < 0.01), longer duration of PsA (OR 1.03, p < 0.01), higher radiographic damaged joint count (OR 1.02, p = 0.04), axial disease (OR 1.73, p < 0.01), and the number of systemic disease-modifying anti-rheumatic drugs (DMARDs) used (OR 1.27, p < 0.01). Male sex (HR 1.54, p = 0.01), vertebral osteopenia (HR 1.39, p = 0.02), and use of non-steroidal anti-inflammatory drugs (HR 1.43, p = 0.03) were associated with the development of TR. Use of biologic and targeted synthetic DMARDs was protective (HR 0.70, p = 0.05), although not significant at the 5 % level. CONCLUSION: TR is a common radiographic feature of PsA. It is associated with more severe disease, including peripheral and axial radiographic damage.
引用
- Kharouf F, Gao S, Pereira D, et al. Tuft resorption in patients with psoriatic arthritis. Semin Arthritis Rheum. 2025. PMID: 40068527. doi:10.1016/j.semarthrit.2025.152701
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。